CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance

CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance

Abstract Coronavirus disease-2019 (COVID-19), as a worldwide serious issue has been shown to lead to progression and poor outcomes in cancer patients. The underlying mechanisms for SARS-CoV-2 infection’s adverse effects on cancer patients have not been fully understood. We hypothesized that CD147 an...

Full description

Bibliographic Details
Main Authors: Maryam Bakhtiyari, Ayda Haji Aghasi, Sara Banihashemi, Arian Abbassioun, Chanour Tavakol, Hamidreza Zalpoor
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Infectious Agents and Cancer
Subjects:
COVID-19
SARS-CoV-2
CD147
Cyclophilin A
Cancer progression
Chemo-resistance
Online Access:https://doi.org/10.1186/s13027-023-00501-2

Internet

https://doi.org/10.1186/s13027-023-00501-2

Similar Items